A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol

Patients with symptomatic advanced chronic obstructive pulmonary disease (COPD) who experience recurrent exacerbations are particularly at risk of poor outcomes and present a significant burden on healthcare systems. The relative merits of treating with different inhaled combination therapies e.g. i...

Podrobná bibliografie
Hlavní autoři:	Pascoe, S, Lipson, D, Locantore, N, Barnacle, H, Brealey, N, Mohindra, R, Dransfield, M, Pavord, I, Barnes, N
Médium:	Journal article
Jazyk:	English
Vydáno:	European Respiratory Society 2016

Podobné jednotky

The association between blood eosinophils and risk and treatment outcome in COPD is not dichotomised
Autor: Pascoe, S, a další
Vydáno: (2018)

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
Autor: David M.G. Halpin, a další
Vydáno: (2018-05-01)

Blood eosinophil levels as a biomarker in COPD
Autor: Brusselle, G, a další
Vydáno: (2018)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
Autor: Siddiqui, S, a další
Vydáno: (2018)

The significance of eosinophilic inflammation in COPD
Autor: Cooper, C, a další
Vydáno: (2017)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
Autor: Siddiqui SH, a další
Vydáno: (2018-11-01)

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial
Autor: Ismaila AS, a další
Vydáno: (2019-11-01)

Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial
Autor: Andrea Benedetti, a další
Vydáno: (2022-07-01)

Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy
Autor: Benson VS, a další
Vydáno: (2019-11-01)

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial
Autor: Lee, LA, a další
Vydáno: (2020)

EFFECTIVENESS OF TRIPLE DRUG FIXED DOSE COMBINATION INHALED THERAPY IN SEVERE COPD PATIENTS
Autor: Vrunda B Patel, a další
Vydáno: (2018-03-01)

SINFONIA study protocol: a phase II/III randomised controlled trial examining benefits of guided online group singing in people with chronic obstructive pulmonary disease and interstitial lung disease and their carers
Autor: Natasha Smallwood, a další
Vydáno: (2022-08-01)

The Lancet COPD Commission: broader questions remain
Autor: Petousi, N, a další
Vydáno: (2023)

DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients
Autor: Hans Gelderblom, a další
Vydáno: (2024-08-01)

Symptomatic COPD: is it time for triple therapy?
Autor: Bafadhel, M
Vydáno: (2018)

Triple therapy in COPD: understanding the data
Autor: Samy Suissa
Vydáno: (2023-01-01)

COPD and hepatitis C.
Autor: Pavord, I, a další
Vydáno: (2003)

COPD: an autoimmune disease?
Autor: Birring, S, a další
Vydáno: (2011)

Whole-body hypothermia in mild neonatal encephalopathy: protocol for a multicentre phase III randomised controlled trial
Autor: Garegrat, R, a další
Vydáno: (2024)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
Autor: Siva, R, a další
Vydáno: (2007)

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients
Autor: López-Campos JL, a další
Vydáno: (2020-07-01)

Inhaled corticosteroids in COPD.
Autor: Brightling, C, a další
Vydáno: (1999)

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial
Autor: Sonja Vliek, a další
Vydáno: (2023-09-01)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
Autor: Pavord, I, a další
Vydáno: (2017)

Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution
Autor: Fulvio Braido, a další
Vydáno: (2022-01-01)

Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial
Autor: Gabrio A, a další
Vydáno: (2022-07-01)

CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial.
Autor: Day, N, a další
Vydáno: (2014)

Mepolizumab for eosinophilic COPD
Autor: Sciurba, F, a další
Vydáno: (2018)

Effect of early palliative care for patients with glioblastoma (EPCOG): a randomised phase III clinical trial protocol
Autor: Stephanie Stock, a další
Vydáno: (2020-01-01)

Whole-body hypothermia in mild neonatal encephalopathy: protocol for a multicentre phase III randomised controlled trial
Autor: Reema Garegrat, a další
Vydáno: (2024-07-01)

The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial
Autor: Lesley Sinclair, a další
Vydáno: (2020-02-01)

Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD
Autor: Singh S, a další
Vydáno: (2018-01-01)

COPD exacerbation phenotypes: The next frontier
Autor: Moran, A, a další
Vydáno: (2019)

Triple Therapy for COPD: Historical Perspective and Current Controversies
Autor: Jose L. López-Campos
Vydáno: (2023-01-01)

Current appraisal of single inhaler triple therapy in COPD
Autor: Lipworth B, a další
Vydáno: (2018-09-01)

Prednisolone response in patients with COPD.
Autor: Pavord, I, a další
Vydáno: (2004)

Inhaled glucocorticoids and COPD exacerbations.
Autor: Brightling, C, a další
Vydáno: (2015)

Determinants of successful completion of pulmonary rehabilitation in COPD
Autor: Brown AT, a další
Vydáno: (2016-02-01)

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial
Autor: Nicola C. Day, a další
Vydáno: (2020-06-01)

Assessment of inflammation in COPD: Observed cell profiles and the effects of treatment
Autor: Pavord, I
Vydáno: (2002)